Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Protection of Telipression on Developing of Acute Kidney Injury in Cirrhotic Patients With Upper-gastroentestinal Bleeding

NCT04358016 is registered in ClinicalTrials.gov with Changhai Hospital as lead sponsor.

NCT NCT04358016
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04358016 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Protection of Telipression on Developing of Acute Kidney Injury in Cirrhotic Patients With Upper-gastroentestinal Bleeding
Lead sponsor
Changhai Hospital
Phase
Phase 4
Overall status
Completed
Start date
January 1, 2018
Completion date
March 1, 2020
Enrollment
54 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cirrhosis, liver, upper gastrointestinal bleeding